The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan. 1, 2027.
Apr 27, 2026
0
12
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether ...
Jul 10, 2026
0
12
Women on menopausal hormone therapy face a decreased risk of low bone mineral density compared with those not using it, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Jun 15, 2026
0
12
Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into ...
May 23, 2026
0
11
A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway—separate from ...
May 6, 2026
0
11
Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some individuals with type 1 diabetes experience cognitive differences, sometimes described as "brain fog," ...
Apr 13, 2026
0
11
In people with type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce energy. As a result, they ...
Apr 30, 2026
0
11
Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure ...
Jun 13, 2026
0
11
Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits—particularly a decrease in symptoms of depression. In a mouse model study published in Cell Host & Microbe, researchers report that ...
Jun 10, 2026
0
11
Type 1 diabetes (T1D) is a lifelong autoimmune disorder where the immune system attacks islets, certain areas of the pancreas, and destroys cells that would otherwise produce insulin, a hormone crucial for regulating blood ...
Jun 3, 2026
0
11
